PET/CT in the imaging of ovarian Cancer

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Owen J. O’Connor¹, Priyanka Prakash², Carmel G. Cronin¹, Shaunagh McDermott¹, Michael A. Blake^1,*

Show Less

¹ Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA

² Department of Radiology, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, USA

*Author to whom correspondence should be addressed.

Front. Biosci. (Elite Ed) 2013, 5(1), 141–153; https://doi.org/10.2741/E603

Published: 1 January 2013

Download PDF

Cite

Abstract

Ovarian cancer is responsible for the largest proportion of deaths among patients with gynecologic cancer. This paper discusses fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the imaging of ovarian cancer. We discuss and demonstrate how FDG PET/CT can be used to appropriately guide clinical management decisions in patients with ovarian cancer. In particular, FDG PET/CT shows great promise for the preoperative evaluation of women with primary ovarian cancer and for subsequent postoperative assessment for recurrence.

Keywords

Ovarian cancer

PET-CT

Oncology

FDG- PET

Review

Previous article in this issue

Next article in this issue

Front. Biosci. (Elite Ed) Print ISSN 1945-0494 Electronic ISSN 1945-0508